Programme SynergiQc pour la recherche biopharmaceutique ### 📋 Eligible Entities - Quebec-based biopharmaceutical companies (all sizes: SMEs, large enterprises) - Research centers acting as collaborative partners - Companies must be legally established in Quebec - Joint projects require formal partnership agreements between company and research institution - Eligible companies include those in drug development, biotechnology, and related biopharmaceutical sectors ### 💰 Funding Details - Grant size: Variable based on project scope and company size - Maximum aid rate: Determined by company size classification (SME vs. large enterprise) - Matching requirements: Cost-sharing model applies; company contribution varies by enterprise classification - Repayability: Non-repayable grant (contribution-based funding) - CQDM support: Funding provided through Commercialisation de la Recherche et Développement en Biotechnologie du Québec (CQDM) ### 🛠️ Approved Expenses - Research & development payroll for project team members - Collaborative research activities conducted at approved research centers - Scientific equipment and instrumentation directly related to project - Materials and supplies for biopharmaceutical research - Consulting and technical expertise services - Project management costs associated with the collaboration - Expenses must support biopharmaceutical innovation and commercialization objectives ### ⚠️ Conditions & Milestones - Partnership requirement: Formal collaboration agreement must exist between Quebec company and research center - Eligibility confirmation: Company must obtain CQDM approval before project launch - Funding varies by company size: Aid rate structure differs for SMEs vs. large enterprises - Eligible expenses only: All spending must align with approved research activities - Reporting obligations: Regular progress reports and financial documentation required - Research center involvement: Active participation and co-investment from research institution expected - Project duration: Timeline subject to individual project approval and milestones - Commercialization focus: Projects must demonstrate biopharmaceutical development or commercialization potential